Does the Type of Surgery after Neoadjuvant Therapy for T3/T4 Breast Cancer Impact Survival?

被引：0
|
作者：
Al-Azhri, J. [1 ]
Koru-Sengul, T. [1 ]
Miao, F. [1 ]
Tannenbaum, S. L. [1 ]
Byrne, M. [1 ]
Alghamdi, H. [1 ]
Saclarides, C. [1 ]
Franceschi, D. [1 ]
Avisar, E. [1 ]
机构：
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2014年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] DOES COMBINATION T4 AND T3 THERAPY MAKE SENSE?
    McDermott, Michael T.
    [J]. ENDOCRINE PRACTICE, 2012, 18 (05) : 750 - 757
  • [2] Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients
    Fitzal, Florian
    Riedl, Otto
    Wutzl, Lisa
    Draxler, Wolfgang
    Rudas, Margaretha
    Pluschnig, Ursula
    Handl-Zeller, Leonore
    Dubsky, Peter
    Bachleitner-Hofmann, Thomas
    Steger, Guenther
    Jakesz, Raimund
    Gnant, Michael
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 103 (01) : 45 - 52
  • [3] Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients
    Florian Fitzal
    Otto Riedl
    Lisa Wutzl
    Wolfgang Draxler
    Margaretha Rudas
    Ursula Pluschnig
    Leonore Handl-Zeller
    Peter Dubsky
    Thomas Bachleitner-Hofmann
    Günther Steger
    Raimund Jakesz
    Michael Gnant
    [J]. Breast Cancer Research and Treatment, 2007, 103 : 45 - 52
  • [4] Combined T4 and T3 therapy
    Utiger, RD
    [J]. THYROID, 2004, 14 (10) : 872 - 872
  • [5] Neoadjuvant docetaxel (T), carboplatin (C), with or without trastuzumab (H) for T3 and T4 breast cancer.
    Chang, HR
    Slamon, D
    Chap, L
    Apple, S
    Glaspy, J
    Lee, P
    Malin, J
    Pegram, M
    Chung, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 89S - 89S
  • [6] NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY SURGERY AND SALVAGE SURGERY FOR THE PATIENTS WITH CLINICAL T3/NEARLY T4 ESOPHAGEAL CANCER
    Saeki, Hiroshi
    Tsutsumi, Satoshi
    Yukaya, Takafumi
    Tajiri, Hirotada
    Tsuda, Yasuo
    Kasagi, Yuta
    Zaitsu, Yoko
    Ando, Koji
    Nakashima, Yuichiro
    Imamura, Yu
    Ohgaki, Kippei
    Oki, Eiji
    Maehara, Yoshihiko
    [J]. ANTICANCER RESEARCH, 2014, 34 (10) : 6149 - 6149
  • [7] Breast conserving therapy after neoadjuvant systemic therapy in patients with T3 breast cancer is feasible
    Van der Noordaa, M.
    Peeters, M. J. Vrancken
    Ioan, I.
    Loo, C.
    Van Urk, J.
    Voorthuis, R.
    Van Werkhoven, E.
    Wiersma, T.
    Dezentje, V.
    Groen, E.
    Rutgers, E.
    Van Duijnhoven, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 92 : S82 - S83
  • [8] Breast conserving therapy after neoadjuvant systemic therapy in patients with T3 breast cancer is feasible
    van der Noordaa, M. E.
    Peeters, M-J M. Vrancken
    Ioan, I.
    Loo, C. E.
    van Urk, J.
    van Werkhoven, E.
    Voorthuis, R.
    Wiersma, T.
    Groen, E.
    Rutgers, E. T.
    van Duijnhoven, F. H.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [9] Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer
    Kenjiro Kotake
    Tomoka Mizuguchi
    Konosuke Moritani
    Osamu Wada
    Heita Ozawa
    Izumi Oki
    Kenichi Sugihara
    [J]. International Journal of Colorectal Disease, 2014, 29 : 847 - 852
  • [10] Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer
    Kotake, Kenjiro
    Mizuguchi, Tomoka
    Moritani, Konosuke
    Wada, Osamu
    Ozawa, Heita
    Oki, Izumi
    Sugihara, Kenichi
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2014, 29 (07) : 847 - 852
12345